![MSL/Senior MSL, Oncology (Kansas City, MO) - ND, SD, NE, KS, MN, IA, MO, WI job with AbbVie | 2851011 MSL/Senior MSL, Oncology (Kansas City, MO) - ND, SD, NE, KS, MN, IA, MO, WI job with AbbVie | 2851011](https://www.biospace.com/images/_display/job/2851011/facebook.png)
MSL/Senior MSL, Oncology (Kansas City, MO) - ND, SD, NE, KS, MN, IA, MO, WI job with AbbVie | 2851011
![Razelle Kurzrock, MD on X: "Cancer of unknown primary CUP Perfect for precision oncology Impact of knowing unknown through multi-omics Rate of SD>=6 months/PR/CR = 71% versus 24% (p= 0.003) for well Razelle Kurzrock, MD on X: "Cancer of unknown primary CUP Perfect for precision oncology Impact of knowing unknown through multi-omics Rate of SD>=6 months/PR/CR = 71% versus 24% (p= 0.003) for well](https://pbs.twimg.com/media/F_J4y_WaMAA-lmf.jpg:large)
Razelle Kurzrock, MD on X: "Cancer of unknown primary CUP Perfect for precision oncology Impact of knowing unknown through multi-omics Rate of SD>=6 months/PR/CR = 71% versus 24% (p= 0.003) for well
![Mathematical and Computational Oncology: Second International Symposium, ISMCO 2020, San Diego, CA, USA, October 8–10, 2020, Proceedings: 12508 (Lecture Notes in Computer Science) : Bebis, George, Alekseyev, Max, Cho, Heyrim, Gevertz, Jana, Mathematical and Computational Oncology: Second International Symposium, ISMCO 2020, San Diego, CA, USA, October 8–10, 2020, Proceedings: 12508 (Lecture Notes in Computer Science) : Bebis, George, Alekseyev, Max, Cho, Heyrim, Gevertz, Jana,](https://m.media-amazon.com/images/I/61RAkv5-lKL._AC_UF1000,1000_QL80_.jpg)
Mathematical and Computational Oncology: Second International Symposium, ISMCO 2020, San Diego, CA, USA, October 8–10, 2020, Proceedings: 12508 (Lecture Notes in Computer Science) : Bebis, George, Alekseyev, Max, Cho, Heyrim, Gevertz, Jana,
![Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists](https://www.outcomes10.com/wp-content/uploads/2022/01/preferences-for-renal-cell-carcicoma-pharmacological-treatment.png)